Inventor · disambiguated record
David Bell
Also filed as: BELL DAVID · BELL DAVID N · BELL DAVID NICHOLSON
8 granted patents·11 pending applications·173 citations·filing 1998–2017
88Inventor score
Top patents by PatentIndex Score
19 records- 0183US8840877B2Polysaccharide-protein conjugates reversibly coupled via imine bondsADAMSON GORD·Filed 2009·Granted Sep 23, 2014·22 cites·24 claims
- 0282US6194207B1Methods for the selective expansion of lymphocytes by in vitro cultivationHEMOSOL INC·Filed 1998·Granted Feb 27, 2001·74 cites·6 claims
- 0372US6361998B1Efficient culture of stem cells for the production of hemoglobinHEMOSOL INC·Filed 1999·Granted Mar 26, 2002·40 cites·15 claims
- 0465US8198401B2Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritisHILL JONATHAN·Filed 2004·Granted Jun 12, 2012·3 cites·6 claims
- 0563US9493539B2Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseasesHILL JONATHAN·Filed 2004·Granted Nov 15, 2016·2 cites·8 claims
- 0663US6610542B1Efficient ex vivo expansion of cd4+ and cd8− T-cells from HIV infected subjectsHEMOSOL INC·Filed 1999·Granted Aug 26, 2003·23 cites·33 claims
- 0754US2005059576A1Targeted delivery of antiviral compounds through hemoglobin bioconjugatesFiled 2004·Application pending·0 cites
- 0853US2017267740A1Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritisLONDON HEALTH SCI CT RES INC·Filed 2017·Application pending·0 cites
- 0951US2012225820A1Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritisHILL JONATHAN·Filed 2012·Application pending·0 cites
- 1047US2007060535A1Targeted delivery of antiviral compounds through hemoglobin bioconjugatesADAMSON J G·Filed 2006·Application pending·0 cites
- 1144US2015010494A1Polysaccharide-protein conjugates reversibly coupled via imine bondsTHERAPURE BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1243US2013209419A1Methods of EngraftmentTHERAPURE BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 1342US6537812B1Methods for the production of TcRγδ+ T cellsHEMOSOL INC·Filed 1999·Granted Mar 25, 2003·9 cites·31 claims
- 1441US2002120098A1Enhanced stimulation of erythropoiesisFiled 2001·Application pending·0 cites
- 1539US7524500B2Method of stimulating stem cellsTHERAPURE BIOPHARMA INC·Filed 2002·Granted Apr 28, 2009·0 cites·6 claims
- 1639US2012213732A1Targeted delivery of antiviral compounds through hemoglobin bioconjugatesADAMSON J GORDON·Filed 2012·Application pending·0 cites
- 1736US2003157060A1Production of tcr gamma delta t cellsFiled 2001·Application pending·0 cites
- 1831US2016158368A1Methods and compositions for the treatment of histiocytosisTHERAPURE BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 1931US2023190947A1Hemoglobin-Targeted Drug Delivery For The Treatment of CancerTHERAPURE BIOPHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Bell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →